Commonwealth Equity Services
CGEM icon

Commonwealth Equity Services’s Cullinan Oncology CGEM Stock Holding History

Commonwealth Equity Services’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,699
Closed -$111K – 4263
2025
Q2 		$111K Sell
14,699
-461
-3% -$3.7K ﹤0.01% 4047
2025
Q1 		$115K Buy
15,160
+656
+5% +$6.29K ﹤0.01% 3971
2024
Q4 		$177K Sell
14,504
-100
-0.7% -$1.44K ﹤0.01% 3801
2024
Q3 		$244K Hold
14,604
– – ﹤0.01% 3529
2024
Q2 		$255K Sell
14,604
-100
-0.7% -$2.13K ﹤0.01% 3441
2024
Q1 		$251K Sell
14,704
-6,255
-30% -$96.6K ﹤0.01% 3438
2023
Q4 		$214K Hold
20,959
– – ﹤0.01% 3453
2023
Q3 		$190K Hold
20,959
– – ﹤0.01% 3398
2023
Q2 		$226K Buy
+20,959
New +$223K ﹤0.01% 3295

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Commonwealth Equity Services's CGEM Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Cullinan Oncology (CGEM) in Q3 2025, closing a stake of 14,699 shares — an estimated $111K sold.

Commonwealth Equity Services first reported a position in CGEM in Q2 2023 and held it in 9 quarters. The position peaked at $255K in Q2 2024. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Cullinan Oncology position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 14,699 Cullinan Oncology shares in Q3 2025, an estimated $111K.
  • Commonwealth Equity Services first reported a position in Cullinan Oncology in Q2 2023 and held it in 9 quarters.
  • Commonwealth Equity Services's Cullinan Oncology position peaked at $255K in Q2 2024.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.